Copyright Notice
Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
Bookshelf ID: NBK500900PMID: 29999959
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 14484-47-0
Drug Levels and Effects
Summary of Use during Lactation
Because no information is available on the use of deflazacort during breastfeeding, an alternate corticosteroid may be preferred, especially while nursing a newborn or preterm infant.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
None reported with any corticosteroid.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
Substance Identification
Substance Name
Deflazacort
CAS Registry Number
14484-47-0
Drug Class
- Breast Feeding
- Lactation
- Corticosteroids, Systemic
- Glucocorticoids
- Anti-Inflammatory Agents
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- Metabolism of deflazacort in the rat, dog and man.[Drug Metab Dispos. 1979]Metabolism of deflazacort in the rat, dog and man.Martinelli E, Ferrari P, Ripamonti A, Tuan G, Perazzi A, Assandri A. Drug Metab Dispos. 1979 Sep-Oct; 7(5):335-9.
- Antiinflammatory activity and other pharmacological properties of 11 beta, 21-dihydroxy-2'-methyl-5' beta H-pregna-1,4 dieno[17,16-d] oxazole 3,20-dione-21-acetate (Deflazacort).[Arzneimittelforschung. 1980]Antiinflammatory activity and other pharmacological properties of 11 beta, 21-dihydroxy-2'-methyl-5' beta H-pregna-1,4 dieno[17,16-d] oxazole 3,20-dione-21-acetate (Deflazacort).Schiatti P, Selva D, Barone D, Restelli A, Glässer A. Arzneimittelforschung. 1980; 30(9):1543-9.
- Review Betamethasone.[Drugs and Lactation Database (...]Review Betamethasone.. Drugs and Lactation Database (LactMed®). 2006
- Review Difluprednate.[Drugs and Lactation Database (...]Review Difluprednate.. Drugs and Lactation Database (LactMed®). 2006
- Review Amcinonide.[Drugs and Lactation Database (...]Review Amcinonide.. Drugs and Lactation Database (LactMed®). 2006
- Deflazacort - Drugs and Lactation Database (LactMed®)Deflazacort - Drugs and Lactation Database (LactMed®)
Your browsing activity is empty.
Activity recording is turned off.
See more...